Pertinence, médecine défensive, surdiagnostic, surmédicalisation

Takada T., Heus P.,  van Doorn S. , Naaktgeboren C., Weenink JW, van Dulmen S., Hooft L. Strategies to reduce the use of low-value medical tests in primary care: a systematic review British Journal of General Practice 2020; 70 (701): e858-e865. DOI: 10.3399/bjgp20X713693

Müskens JLJM, Kool RB, van Dulmen SA, et al Overuse of diagnostic testing in healthcare : a systematic review BMJ Quality & Safety 2022;31:54-63.

Gram, E. G., Siersma, V., & Brodersen, J. B. (2023). Long-term psychosocial consequences of false-positive screening mammography: a cohort study with follow-up of 12–14 years in Denmark. BMJ Open, 13(4), e072188.BMJ.

Tussing AD, Wojtowycz MA. Malpractice, defensive medicine, and obstetric behavior, Med Care. 1997 Feb;35(2):172-91.

Summerton N. (2000), Trends in negative defensive medicine within general practice, Br. J. Gen. Pract., No. 50(456): 565-6.

•    Mazor KM, Simon SR, Yood RA, et al. Health plan members’ views about disclosure of medical errors. Ann Intern Med. 2004;140:409-418.

Studdert D., Mello M., Sage W., Desroches C., Peugh J., Zapert K., Brennan T. Defensive Medicine Among High-Risk Specialist Physicians in a Volatile Malpractice Environment, JAMA. 2005;293(21):2609-2617

Werner RM, Asch DA (2005) The unintended consequences of publicly reporting quality information. JAMA 293(10):1239-44

Weissman J., Annas C. Epstein A., Schneider E., Clarridge B., Kirle L. Gatsonis C/; Feibelmann S., Ridley N. Error Reporting and Disclosure Systems Views From Hospital Leaders, JAMA. 2005;293(11):1359-1366

Narins C., Dozier, A., Ling F., Zareba W. The influence of Public reporting of outcome data on medical decision making by physician, Arch Int Med, 2005, 165:83_87

Bismark MM, Brennan TA, Paterson RJ, “et al.”(2006) Relationship between complaints and quality of care in New Zealand: a descriptive analysis of complainants and non-complainants following adverse events. Qual Saf Health Care. 15(1):17-22

Barbot J., Fillion E. La « médecine défensive » : critique d'un concept à succès , Sciences sociales et santé, 24-2, 2006 : 5-33

Hiyama T, Yoshihara M, Tanaka S, Urabe Y, Ikegami Y, Fukuhara T, et al. Defensive medicine practices among gastroenterologists in Japan. World J Gastroenterol. 2006;12:7671–5.

Studdert DM, Mello MM, Gawande AA “et al.” (2007) Disclosure of medical injury to patients: an improbable risk management strategy. Health Affairs (Millwood). 26(1):215-26.

Sethi D., Aseltine R., Gulla R. MMS First-of-its-kind Survey of Physicians Shows Extent and Cost of the Practice of Defensive Medicine and its Multiple Effects of Health Care on the State

Hermer L., Brody H. Defensive medicine, cost containment and reform, J Gen Intern Med 25(5):470–3

Langel  S. Adverting Medical Malpractice lawsuits :effective medecine- or inadequate cure ?Health affairs, 2010, 29,9,1565-68

Thomas J., Ziller E., Thayer D. Low costs of defensive medicine, small savings from tort reform, Health Affairs, 2010 vol. 29 no. 9 1578-1584

Bishop. T., Federman A. Keyhani S. Physicians’ views on Defensive Medicine : A national Survey Arch int Med, 2010, 170 : 1081-1083

Welch G., Black W. Over diagnostic in cancer, J Natl Cancer Instute, 2010 :102 :605-13

Rapport d’orientation de la HAS, Dépistage du cancer de la prostate, analyse critique des articles issus des études ERSPC et PLCO publiées en mars 2009, Juin 2010

Grady D., Redbeg R. Less is more, Arch Int Med, 2010, 170, 9, 748-50

Catino M. Why do doctors practice defensive medicine? The side effect of medical litigation, Safety Science Monitor, 1, 2011, 15, article 4

Cunningham W., Wilson H. Complaints, Shame and defensive medicine, BMJ QUal Saf 2011, 20, 449-52

Baldwin, L., Trivers, K., Matthews, B., Holly C., Andrilla, A., Miller, J, Berry, D., Lishner, D., Goff, B. Vignette-Based Study of Ovarian Cancer Screening: Do U.S. Physicians Report Adhering to Evidence-Based Recommendations? Ann Intern Med. 2012;156:182-194.

Moynihan, R, Doust J., Henry D. Preventing overdiagnosis: how to stop harming the healthy BMJ 2012; 344: e3502

Simmons R., Echouffo-Tcheugui J., Sharp S., Sargeant L. Williams K., Prevost T., Kinmonth AL, Wereham N., Griffin S. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial The Lancet, Early Online Publication, 4 October 2012 doi:10.1016/S0140-6736(12)61422-6

La Fédération hospitalière de France a rendu public les résultats du sondage mené auprès de plus de 800 médecins hospitaliers et libéraux sur leur opinion quant aux pratiques d’actes injustifiés. Sondage "Les médecins face aux pratiques d'actes injustifiés"

Medscape France,  Sur-traitement du cancer de la prostate : une réalité en France, 2013

Sekkar S., Vyas N., Defensive Medicine: A Bane to Healthcare, Ann Med Health Sci Res, Apr-jun 3(2) 295-6

Mello M, Studdert D, et Kachalia A.  The medical liability climate and prospects for reform JAMA 312, no 20 (26 novembre 2014): 2146 55.

Waxmann D., Greenberg M., Ridgely S., Kellermann A., Heaton P., The Effect of Malpractice Reform on Emergency Department Care, N Eng J Med 2014, 371, 1518-25

Carter, J., Coletti R., Harris R..  Quantifying and Monitoring Overdiagnosis in Cancer Screening: A Systematic Review of Methods . BMJ 350, no jan07 5 (7 janvier 2015): g7773 g7773.

Hoffmann, T., Del Mar C.  Patients’ Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review  JAMA Internal Medicine 175, no 2 (1 février 2015): 274.

2010-AAOS-Hettrich- The costs of defensive medicine  Carolyn M. Hettrich, MD, MPH; Richard C. Mather III, MD; Manish K. Sethi, MD; Ryan M. Nunley, MD; Amir A. Jahangir, MD, and the Washington Health Policy Fellows

Nazione, S., & Pace, K. (2015). An Experimental Study of Medical Error Explanations: Do Apology, Empathy, Corrective Action, and Compensation Alter Intentions and Attitudes?. Journal of health communication, (ahead-of-print), 1-11.

Nazione, S., & Pace, K. (2015). An Experimental Study of Medical Error Explanations: Do Apology, Empathy, Corrective Action, and Compensation Alter Intentions and Attitudes?. Journal of health communication, (ahead-of-print), 1-11.

Anupam J., Schoemaker L., Bhattacharya J., Seabury S.. Physician Spending and Subsequent Risk of Malpractice Claims: Observational Study BMJ 351 (4 novembre 2015): h5516.

Un numéro spécial d'ADSP coordonné par le Haut Conseil en Santé Publique sur la pertinence des soins.

SHen Q., Schelin M., Joud A., Cao Y., Adami, H., Cnattingius S., Fall K., Valdimarsdottir, U., Injuries before and after diagnosis of cancer, : nationwide register based study, BMJ 2016, 354 :i4218

Kearney M., Treadwell J., Marshall M., Overtreatment and undertreatment: time to challenge our thinking Br J Gen Pract 2017;  67 (663): 442443.

Brito Juan P, Morris John C, Montori Victor M. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours  BMJ  2013;  347 :f4706

Selby K., Cornuz J., Cohidon C., Gaspoz J., Senn N. (2018) How do Swiss general practitioners agree with and report adhering to a top-five list of unnecessary tests and treatments? Results of a cross-sectional survey, European Journal of General Practice, 24:1, 32-38, DOI: 10.1080/13814788.2017.1395018

Klarenbach S., Sims-Jones N., Lewin G., Singh H., Thériault G., Tonelli M., Doull M.,  Courage S.,  Jaramillo Garcia A., Thombs B.  for the Canadian Task Force on Preventive Health Care Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer CMAJ 2018 December 10;190:E1441-51. doi: 10.1503/cmaj.180463

Mandl, K. D., & Manrai, A. K. (2019) Potential Excessive Testing at Scale: Biomarkers, Genomics, and Machine Learning, JAMA. 2019;321(8):739-740.

Badgery-Parker T., Pearson S., Dunn S., Elshaug G. Measuring Hospital-Acquired Complications Associated With Low-Value Care, JAMA Intern Med. 2019;179(4):499-505. doi:10.1001/jamainternmed.2018.7464

Badgery-Parker T, Pearson S, Dunn S, Elshaug AG. Measuring Hospital-Acquired Complications Associated With Low-Value Care. JAMA Intern Med. 2019;179(4):499–505. doi:10.1001/jamainternmed.2018.7464

Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA. Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States. JAMA Oncol. 2019;5(5):735–737. doi:10.1001/jamaoncol.2019.0349